Xoma Ltd.
🏢 View company profile →144Patents
0Active
144Granted
40Portfolio score
Filing activity: Oct 18, 1982 → Jul 16, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5500362A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 777 | Expired |
| US5766886A | Modified antibody variable domains | Physics | 431 | Expired |
| US5618920A | Modular assembly of antibody genes, antibodies prepared thereby and use | Chemistry; Metallurgy | 290 | Expired |
| US6204023A | Modular assembly of antibody genes, antibodies prepared thereby and use | Chemistry; Metallurgy | 238 | Expired |
| US5576184A | Production of chimeric mouse-human antibodies with specificity to human tumor antigens | Emerging Cross-Sectional Technologies | 192 | Expired |
| US5869619A | Modified antibody variable domains | Chemistry; Metallurgy | 182 | Expired |
| US5677180A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 131 | Expired |
| US5693493A | Modular assembly of antibody genes, antibodies prepared thereby and use | Chemistry; Metallurgy | 128 | Expired |
| US5698417A | Modular assembly of antibody genes, antibodies prepared thereby and use | Chemistry; Metallurgy | 119 | Expired |
| US5721108A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 113 | Expired |
| US4925922A | Potentiation of cytotoxic conjugates | Emerging Cross-Sectional Technologies | 103 | Expired |
| US4916213A | Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof | Emerging Cross-Sectional Technologies | 86 | Expired |
| US5348942A | Therapeutic uses of bactericidal/permeability increasing protein products | Human Necessities | 81 | Expired |
| US5698435A | Modular assembly of antibody genes, antibodies prepared thereby and use | Chemistry; Metallurgy | 72 | Expired |
| US5595898A | Modular assembly of antibody genes, antibodies prepared thereby and use | Chemistry; Metallurgy | 71 | Expired |
| US5846818A | Pectate lyase signal sequence | Chemistry; Metallurgy | 70 | Expired |
| US5576195A | Vectors with pectate lyase signal sequence | Chemistry; Metallurgy | 69 | Expired |
| US4489710A | Composition and method for transplantation therapy | Emerging Cross-Sectional Technologies | 60 | Expired |
| US4590071A | Human melanoma specific immunotoxins | Human Necessities | 51 | Expired |
| US5420019A | Stable bactericidal/permeability-increasing protein muteins | Chemistry; Metallurgy | 47 | Expired |
| US5028530A | AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques | Chemistry; Metallurgy | 46 | Expired |
| US5578572A | Anti-gram-positive bacterial methods and materials | Human Necessities | 45 | Expired |
| US5523288A | Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and antibiotic | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5821123A | Modified antibody variable domains | Physics | 44 | Expired |
| US5488034A | Pharmaceutical composition comprising BPI proteins | Human Necessities | 39 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.